BSE demat auction for settlement number 779 listing securities and quantities to be auctioned across multiple scrips.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting multiple securities with moderate quantities; operational impact on specific scrips and their shareholders with delivery obligations.
BSE demat auction settlement listing securities and quantities for various scrips under settlement number 779.
Impact
Medium
Severity
Medium
Justification
Demat auction settlements affect specific scrips and their trading members. This is a routine operational circular impacting parties with failed delivery obligations for 87 securities.
BSE demat auction for settlement number 778 covering delivery shortfalls across 96 scrips with quantities ranging from 1 to 10 million shares.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting 96 scrips with varying quantities. While operationally significant for affected members, this is a standard settlement mechanism for delivery shortfalls.
BSE announces demat auction settlement no. 778 dated December 17, 2025, listing 93 securities with specified quantities for auction settlement.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting multiple securities. Important for brokers and clearing members to fulfill delivery obligations but standard operational procedure.
BSE demat auction settlement No. 777 listing securities available for auction to cover short delivery obligations dated December 16, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction for settlement 777 involving 103 securities with varying quantities. Impacts brokers and traders with short delivery obligations but is a standard market mechanism.
Shareholding pattern filing under Reg. 31(1)(a) for Corona Remedies Limited post-issue as of December 12, 2025, showing promoter holding at 68.9959% and public holding at 31.0041%.
Impact
Low
Severity
Low
Justification
Routine shareholding pattern disclosure for newly listed equity shares with standard promoter-public distribution and high dematerialization rate